Angstrom Bio, Inc. is a biotechnology startup founded in 2019 with the slogan "Machine Intelligence for Human Health." The company applies modern machine intelligence to the study, diagnosis, and treatment of disease with the goal of generating cures. Operating in the United States, Angstrom Bio recently received a $3.00M Seed Round investment on 16 June 2021, with GreyBird Ventures as the lead investor. Specializing in the intersection of biotechnology, health care, and life sciences, Angstrom Bio, Inc. shows promise in leveraging cutting-edge technology to revolutionize the healthcare sector.